Restech offers minimally invasive tools to multiple specialties in order to accurately diagnose and manage reflux, and will continue to create solutions related to the complexity gastric related diseases. Restech’s tools are helping evolve the standard of care for patients with reflux, and fecal incontinence, providing physicians with the necessary data to transform the algorithm of care for tens of millions of patients.
Looking for a particular Restech employee's phone or email?
The Restech annual revenue was $6.1 million in 2026.
Debra Krahel is the President, CEO of Restech.
27 people are employed at Restech.
Restech is based in Houston, Texas.
The NAICS codes for Restech are [33, 339, 334].
The SIC codes for Restech are [38, 384].